CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer

by Yuan-ke Liang, Yuan-ke Liang, Ze-kun- Deng, Mu-tong Chen, Si-qi Qiu, Si-qi Qiu, Ying-sheng Xiao, Ying-sheng Xiao, Yu-zhu Qi, Yu-zhu Qi, Qin Xie, Zheng-hao Wang, Shi-cheng Jia, De Zeng, De Zeng, Hao-yu Lin, Hao-yu Lin
Published 2021-08-01

Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.

by Yong-Qu Zhang, Xiao-Long Wei, Yuan-Ke Liang, Wei-Ling Chen, Fan Zhang, Jing-Wen Bai, Si-Qi Qiu, Cai-Wen Du, Wen-He Huang, Guo-Jun Zhang
Published 2015-01-01

Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model

by Frans V. Suurs, Si-Qi Qiu, Joshua J. Yim, Carolien P. Schröder, Hetty Timmer-Bosscha, Eric S. Bensen, John T. Santini, Elisabeth G. E. de Vries, Matthew Bogyo, Gooitzen M. van Dam
Published 2020-09-01

Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers

by Marjory Koller, Si-Qi Qiu, Matthijs D. Linssen, Liesbeth Jansen, Wendy Kelder, Jakob de Vries, Inge Kruithof, Guo-Jun Zhang, Dominic J. Robinson, Wouter B. Nagengast, Annelies Jorritsma-Smit, Bert van der Vegt, Gooitzen M. van Dam
Published 2018-09-01

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

by Si-Qi Qiu, Johan van Rooijen, Hilde H. Nienhuis, Bert van der Vegt, Hetty Timmer-Bosscha, Elise van Leeuwen-Stok, Annemiek M. E. Walenkamp, Carolien H. M. van Deurzen, Geertruida H. de Bock, Elisabeth G. E. de Vries, Carolien P. Schröder
Published 2020-03-01